Back to School: How biopharma can reboot drug development. Access exclusive analysis here
JNJ said it is recalling certain batches of its Eprex epoetin alfa anemia drug in
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury